Providence First Trust’s AbbVie ABBV Stock Holding History

Providence First Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,097	Closed	-$708K	–	180
2025 Q4	$708K	Buy	+3,097	New	+$706K	0.25%	94
2025 Q1	–	Sell	-19	Closed	-$3.38K	–	102
2024 Q4	$3.38K	Buy	+19	New	+$3.49K	﹤0.01%	201
2022 Q4	–	Sell	-19	Closed	-$3K	–	94
2022 Q3	$3K	Buy	+19	New	+$2.73K	﹤0.01%	135

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Providence First Trust's ABBV Position: Q1 2026 in Review

Providence First Trust sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 3,097 shares — an estimated $708K sold.

Providence First Trust first reported a position in ABBV in Q3 2022 and held it in 3 quarters. The position peaked at $708K in Q4 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Providence First Trust reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Providence First Trust sold 3,097 AbbVie shares in Q1 2026, an estimated $708K.
Providence First Trust first reported a position in AbbVie in Q3 2022 and held it in 3 quarters.
Providence First Trust's AbbVie position peaked at $708K in Q4 2025.
4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Providence First Trust's 13F filing for Q1 2026, filed 5 May 2026.